Today, a clinical team in the Hurvitz Brain Sciences Program has taken the next step in advancing dementia care by performing Canada’s first patient infusion of lecanemab, a disease-modifying therapy used to treat mild cognitive impairment or mild dementia caused by Alzheimer’s disease. The therapy was recently approved by Health Canada, after having shown to slow down the pr...
Following Sunnybrook Health Sciences Centre's news feed is very easy. Subscribe using the "follow" button on the top right and if you want to, choose the updates by topic or tag.
We will deliver them to your inbox, your phone, or you can use follow.it like your own online RSS reader. You can unsubscribe whenever you want with one click.
Keep up to date with Sunnybrook Health Sciences Centre!
Sunnybrook Health Sciences Centre: Sunnybrook Health Sciences Centre
